Jade Competitors
| JBIO Stock | 14.39 1.61 10.06% |
Jade Biosciences vs AC Immune Correlation
Significant diversification
The correlation between Jade Biosciences and ACIU is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jade Biosciences and ACIU in the same portfolio, assuming nothing else is changed.
Moving together with Jade Stock
Moving against Jade Stock
| 0.84 | EVGN | Evogene | PairCorr |
| 0.82 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.77 | GNLX | Genelux Common | PairCorr |
| 0.75 | QSI | QuantumSi | PairCorr |
| 0.68 | EDIT | Editas Medicine | PairCorr |
Jade Biosciences Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Jade Biosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Jade and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Jade Biosciences does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jade Stock performing well and Jade Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jade Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SLN | 3.06 | (0.63) | 0.00 | (1.85) | 0.00 | 6.88 | 23.80 | |||
| LYEL | 4.27 | 0.57 | 0.12 | 0.59 | 4.45 | 12.12 | 31.14 | |||
| ALDX | 3.66 | 0.16 | 0.03 | (10.29) | 4.48 | 6.27 | 42.93 | |||
| KYTX | 5.79 | 0.53 | 0.05 | (0.54) | 8.20 | 9.57 | 55.75 | |||
| CTNM | 3.36 | 0.55 | 0.11 | (0.71) | 4.03 | 7.99 | 23.16 | |||
| GNLX | 3.96 | (1.47) | 0.00 | (24.72) | 0.00 | 5.67 | 34.38 | |||
| XOMA | 3.00 | (0.33) | 0.00 | (1.65) | 0.00 | 5.27 | 29.87 | |||
| TECX | 3.42 | 0.41 | 0.11 | 0.65 | 3.49 | 8.09 | 22.59 | |||
| ACIU | 3.60 | (0.17) | 0.00 | (0.05) | 0.00 | 7.01 | 26.05 |
Cross Equities Net Income Analysis
Compare Jade Biosciences and related stocks such as Silence Therapeutics PLC, Lyell Immunopharma, and Aldeyra Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLN | (874 K) | (5.7 M) | (26.3 M) | (9 M) | (11.1 M) | (6.6 M) | (8.4 M) | (1.6 M) | (18.4 M) | (19.6 M) | (32.5 M) | (39.4 M) | (50.3 M) | (43.3 M) | (45.3 M) | (40.8 M) | (38.7 M) |
| LYEL | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (129.4 M) | (204.5 M) | (250.2 M) | (183.1 M) | (234.6 M) | (343 M) | (308.7 M) | (324.1 M) |
| ALDX | (2.4 M) | (2.4 M) | (23.1 M) | 13.1 M | (5.2 M) | (12.1 M) | (18.7 M) | (22.3 M) | (38.9 M) | (60.8 M) | (37.6 M) | (57.8 M) | (62 M) | (37.5 M) | (55.9 M) | (50.3 M) | (47.8 M) |
| KYTX | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (26.4 M) | (28.9 M) | (60.4 M) | (127.5 M) | (114.7 M) | (109 M) |
| CTNM | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (29 M) | (24.3 M) | 22.7 M | (42.3 M) | (48.6 M) | (46.2 M) |
| GNLX | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (14.9 M) | (17.8 M) | (5.2 M) | (28.3 M) | (29.9 M) | (26.9 M) | (28.2 M) |
| XOMA | (4.8 M) | (32.7 M) | (71.1 M) | (124.1 M) | (38.3 M) | (20.6 M) | (53.5 M) | 14.6 M | (13.3 M) | (2 M) | 13.3 M | 15.8 M | (17.1 M) | (40.8 M) | (13.8 M) | (15.9 M) | (16.7 M) |
| TECX | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (18.6 M) | (46.4 M) | (73 M) | (119.7 M) | (8.9 M) | (32.2 M) | (42.8 M) | (58 M) | (52.2 M) | (54.8 M) |
| ACIU | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | 10.7 M | 20.3 M | (7.1 M) | (26.4 M) | (51 M) | 45.4 M | (61.9 M) | (73 M) | (70.8 M) | (54.2 M) | (50.9 M) | (45.8 M) | (43.5 M) |
Jade Biosciences and related stocks such as Silence Therapeutics PLC, Lyell Immunopharma, and Aldeyra Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Jade Biosciences financial statement analysis. It represents the amount of money remaining after all of Jade Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Jade Biosciences Competitive Analysis
The better you understand Jade Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Jade Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Jade Biosciences' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Jade Biosciences Competition Performance Charts
Five steps to successful analysis of Jade Biosciences Competition
Jade Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Jade Biosciences in relation to its competition. Jade Biosciences' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Jade Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Jade Biosciences' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Jade Biosciences, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Jade Biosciences position
In addition to having Jade Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Jade Biosciences Correlation with its peers. To learn how to invest in Jade Stock, please use our How to Invest in Jade Biosciences guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Will Biotechnology sector continue expanding? Could Jade diversify its offerings? Factors like these will boost the valuation of Jade Biosciences. Expected growth trajectory for Jade significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Jade Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Jade Biosciences's market price often diverges from its book value, the accounting figure shown on Jade's balance sheet. Smart investors calculate Jade Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Jade Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Jade Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Jade Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Jade Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.